21490 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds Peptides, e.g. proteins
Sub-classes:PHYTIC ACID-BASED TERNARY COMPLEX BIOMIMETIC NANOMATERIAL, AND PREPARATION METHOD AND USE THEREOF
#2TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#3Brevican-Binding Peptides for Brain Tumor Imaging
#4Panel comprising Borrelia MHC multimers
#5COMPOSITIONS OF AND METHODS OF MAKING FERRITIN-BASED IMAGING AGENTS
#6Mapping glutathione deficiency and/or dysfunction of mitochondria
#7MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT
#8METHODS USING SURFACE-EXPRESSIBLE ACTIVATABLE EPITOPES TO LOCALIZE AND/OR TREAT DISEASED CELLS
#9COMPOSITION AND METHODS FOR IMAGING CELLS
#10TISSUE-SPECIFIC MANGANESE BASED MRI CONTRAST AGENTS
#11MAGNETIC FERROFERRIC OXIDE NANOPARTICLE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#12METHODS FOR MAGNETIC RESONANCE IMAGING OF NANOCONSTRUCTS AND USES THEREOF
#13COMPOSITIONS AND METHODS RELATING TO CELLS WITH ADHERED PARTICLES
#14DIAGNOSIS AND MONITORING USING EXTRADOMAIN-B FIBRONECTIN TARGETED PROBES
#15CONTRAST AGENT, PREPARATION METHOD FOR CONTRAST AGENT, AND APPLICATION OF CONTRAST AGENT
#16PEPTIDE LIBRARIES WITH NON-CANONICAL AMINO ACIDS
#17MOLECULAR PROBES AND METHODS OF USE
#18FLUORINATED FIBERS FOR MULTIMODAL 1H AND 19F MRI, ULTRASOUND, FLUORESCENCE DETECTION AND CONFORMATIONAL AND TEMPERATURE DETECTION BY 19F MRS
#19CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING
#20CEST-MRI Methods for Detection of Diseases
#21CLOT DETECTION AND TREATMENT METHODS AND SYSTEMS
#22REACTIVE CONJUGATES
#23EPCAM BINDING FIBRONECTIN TYPE III DOMAINS
#24TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#25CAR Peptide for Improved Coronavirus Survival
#26TUMOR-TARGETING, CLEARABLE HUMAN PROTEIN-BASED MRI NANOPROBES, AND COMPOSITIONS AND METHODS THEREOF
#27Cyclen based compounds, coordination compounds, peptides, pharmaceutical preparation, and use thereof
#28APOHEMOGLOBIN-HAPTOGLOBIN COMPLEXES AND METHODS OF USING THEREOF
#29COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#30Compositions of and methods of making ferritin-based imaging agents
#31COMPOSITION AND COMPOSITE
#32Panel comprising MHC multimers
#33Brevican-Binding Peptides for Brain Tumor Imaging
#34PEPTIDES AND COMPOSITIONS FOR TARGETED TREATMENT AND IMAGING
#35Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof
#36Peptide compositions for immuno-oncology molecular imaging and targeted drug delivery
#37Molecular probes and methods of use
#38HALOGENATED BIOTIN-MODIFIED DIMER AND USE THEREOF
#39MULTI-COMPONENT NANOCHAINS
#40Dual-targeted carbonic anhydrase ix complex and contrast agent thereof
#41Compositions for use in lysis of selective cancer cells
#42Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#43MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT
#44Combination therapy of electric fields and an additional treatment for cancer and imaging
#45METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER
#46Contrast agents, methods for preparing contrast agents, and methods of imaging
#47Manganese-based chelate conjugates for molecular MR imaging
#48AMYLOID-BINDING COMPOUNDS AND METHODS OF USE THEREOF
#49MAGNETIC RESONANCE IMAGING (MRI) CONTRAST AGENTS AND USE THEREOF
#50MALIGNANT TUMOR TARGET PEPTIDE
#51Biospecific agents for bone
#52METHODS AND COMPOSITIONS FOR EFFICIENT DELIVERY THROUGH MULTIPLE BIO BARRIERS
#53Tumor-targeting, clearable human protein-based MRI nanoprobes, and compositions and methods thereof
#54Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy
#55Peptide libraries with non-canonical amino acids
#56USING ENDOSCOPY AS A CHANNEL TO DELIVER CANCER-OR TISSUE-TARGETED THERANOSTIC AGENTS
#57Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#58TARGETED CONTRAST AGENTS AND METHODS FOR TARGETING CONTRAST AGENTS
#59Modified variable domain molecules and methods for producing them
#60Compounds that bind to human immunodeficiency virus rev response element
#61GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL
#62METHODS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS WITH ENHANCED PHARMACOLOGICAL PROPERTIES
#63Composition and methods for imaging cells
#64MOLECULAR IMAGING CONTRAST AGENTS AND USES THEREOF
#65Central nervous system homing peptides and uses thereof
#66VAP polypeptide and use thereof in preparation of drug for targeted diagnosis and treatment of tumor
#67MOLECULAR SENSOR FOR NMR/MRI BASED ON ANALYTE-DEPENDENT SPECTRAL CHANGES OF TEMPORARILY ENCAPSULATED HYPERPOLARIZED 129XE
#68Multi-component nanochains
#69MRI-based systems and methods for determining function capacity of the kidney
#70Targeting peptides and methods of use
#71Protein reporters for ultrasensitive detection methods
#72Compounds and methods for the detection of TRPV-6 cancers and drug delivery
#73Plectin-1 Targeted Agents for Detection and Treatment of Pancreatic Ductal Adenocarcinoma
#74Malignant tumor target peptide
#75HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES
#76PAMAM dendrimer based CEST imaging agents and uses thereof
#77MRI and CT contrast-enabled composite implants for image-guided tissue regeneration and therapy
#78GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL
#79Manganese-based chelate conjugates for molecular MR imaging
#80Peptides that target inflamed or distressed cardiac tissue and uses related thereto
#81Contrast agents, methods for preparing contrast agents, and methods of imaging
#82CONTRAST-AGENT-LABELED PEPTIDE AMPHIPHILE NANOFIBERS
#83Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors
#84Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#85COLLAGEN IMAGING COMPOSTIONS
#86Molecular probes and methods of use
#87STRUCTURE AND FUNCTION OF THE SALICYCLIC ACID BINDING SITES ON HUMAN HMGB1 AND METHODS OF USE THEREOF FOR THE RATIONAL DESIGN OF BOTH SALICYCLIC ACID DERIVATIVES AND OTHER AGENTS THAT ALTER ANIMAL AND PLANT HMGBS ACTIVITIES
#88Electron spin labeled ice binding compounds used for carrying paramagnetic centers for dynamic nuclear polarization
#89Dual-modality imaging probe for combined localization and apoptosis detection of stem cells
#90Homing agents
#91HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES
#92Sprr1A as a genetic target for treating neurodegenerative diseases
#93Modular Imaging Agents Containing Amino Acids and Peptides
#94MODIFIED VARIABLE DOMAIN MOLECULES AND METHODS FOR PRODUCING THEM
#95Hydrophobin mimics: process for preparation thereof
#96Targeting peptides and methods of use
#97SELF-ASSEMBLING MOLECULES THAT ACCUMULATE IN ACIDIC TUMOR MICROENVIRONMENTS
#98Multi-component nanochains
#99Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
#100DOTAM DERIVATIVES FOR THERAPEUTIC USE
#101Peptides whose uptake by cells is controllable
#102EXENDIN-4 PEPTIDE ANALOGUES AS DUAL GLP-1/GLUCAGON RECEPTOR AGONISTS
#103Engineered fluorinated biomaterials
#104ENZYME DIRECTED ASSEMBLY OF PARTICLE THERANOSTICS
#105Collagen imaging compositions
#106Collagen Imaging Compositions
#107Activatable fibrin-binding probes
#108Environmentally sensitive compositions and methods of use thereof
#109Targeted contrast agents and methods for targeting contrast agents
#110Compounds that bind to human immunodeficiency virus rev response element
#111Electron spin labeled ice binding compounds used for carrying paramagnetic centers for dynamic nuclear polarization
#112Ligands to radiation-induced molecules
#113Multimodal imaging of fibrin
#114MAGNETIC NANOPARTICLE AND METHOD FOR IMAGING T CELLS
#115Labeled ligands of anti-Mullerian hormone for diagnosis of endometriosis
#116EXENDIN-4 PEPTIDE ANALOGUES AS DUAL GLP-1/GLUCAGON RECEPTOR AGONISTS
#117Cell-penetrating peptide, conjugate comprising same and composition comprising same
#118Methods and compositions for delivering active agents with enhanced pharmacological properties
#119Peptide hydrogels generating chemical exchange saturation transfer MRI contrast and uses thereof
#120Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#121Functionalized naphthalene fluorophores
#122Cupredoxin derived transport agents and methods of use thereof
#123Metallocene compounds and labeled molecules comprising the same for in vivo imaging
#124METAL CHELATE COMPOUNDS FOR BINDING TO THE PLATELET SPECIFIC GLYCOPROTEIN IIB/IIIA
#125MRI CONTRAST AGENT INCLUDING T1 CONTRAST MATERIAL COATED ON SURFACE OF NANOPARTICLE SUPPORT
#126BRAIN TUMOR TARGETING PEPTIDES AND METHODS
#127BIOSPECIFIC AGENTS FOR BONE
#128MRI-based systems and methods for determining function capacity of the kidney
#129Synthesis, structure and use of functionalized naphthalenes
#130Manganese-based magnetic resonance contrast agents
#131MANGANESE-BASED MAGNETIC RESONANCE CONTRAST AGENTS
#132PEPTIDIC STRUCTURES INCORPORATING AN AMINO ACID METAL COMPLEX AND APPLICATIONS IN MAGNETIC RESONANCE IMAGING
#133Dual mode gadolinium nanoparticle contrast agents
#134Molecular imaging contrast agents and uses thereof
#135AL-F-18-LABELED, AL-F-19-LABELED AND GA-68-LABELED GASTRIN-RELEASING PEPTIDE RECEPTOR (GRPR)-ANTAGONISTS FOR IMAGING OF PROSTATE CANCER
#136Contrast agents, methods for preparing contrast agents, and methods of imaging
#137Compounds and methods for the detection of TRPV-6 cancers and drug delivery
#138Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#139COMPOUNDS HAVING MAGNETIC FUNCTIONALITY, IMPLANTS OR GELS DERIVED FROM SAME, AND USE OF BOTH IN ORDER TO DETERMINE THE ENZYME ACTIVITY OF AN ENZYME
#140Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
#141Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides
#142CELL-TARGETED MAGNETIC NANO-MATERIAL AND BIOMEDICAL USES THEREOF
#143Environmentally sensitive compositions and methods of use in the treatment and diagnosis of tumors
#144Modular imaging agents containing amino acids and peptides
#145Homing agents
#146MOLECULAR AND CELLULAR IMAGING USING ENGINEERED HEMODYNAMIC RESPONSES
#147Methods and compositions related to targeting tumors and wounds
#148Ligands to radiation-induced molecules
#149PROCASPASE 8-MEDIATED DISEASE TARGETING
#150Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI
#151Hydrophobic modified peptides for liver specific diagnosis
#152Compounds modulators of VEGF activity and uses thereof
#153SYNTHETIC DIBLOCK COPOLYPEPTIDE HYDROGELS FOR USE IN THE CENTRAL NERVOUS SYSTEM
#154NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS
#155Cyclic lactadherin peptide mimetics and their uses
#156Polypeptides
#157Method for the detection of enzymatic activity with magnetically functionalized substrates
#158Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides
#159RGD-containing peptidomimetics and uses thereof
#160Compounds for diagnosing diseases associated with the expression of MUC5AC
#161Melanocortin 1 receptor ligands and methods of use
#162Method of screening for colon cancer using biomarkers
#163Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs
#164Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#165VISUALIZATION OF LIPID METABOLISM
#166Cupredoxin derived transport agents and methods of use thereof
#167MRI contrast agents
#168Reporter genes for magnetic resonance imaging and methods of use thereof
#169Ligands to radiation-induced molecules
#170Agents for the molecular imaging of serine-protease in human pathologies
#171CONTRAST AGENTS
#172METHODS AND COMPOSITIONS FOR DIAGNOSIS OF IGA-AND IGM-MEDIATED KIDNEY DISEASES
#173Compositions and methods to prevent cancer with cupredoxins
#174Formation and uses of europium complexes
#175Activatable cell penetrating peptides with quenched fluorophores
#176EGF RECEPTOR MIMICKING PEPTIDES
#177Chemical exchange saturation transfer based MRI using reporter genes and MRI methods related thereto
#178Methods and compositions relating to reporter gels for use in MRI techniques
#179Compositions and methods comprising magnetic resonance contrast agents
#180Cupredoxin derived transport agents and methods of use thereof
#181Polypeptides
#182Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof
#183Fibrin-binding peptides and conjugates thereof
#184Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
#185Contrast agents and methods for preparing contrast agents
#186Fibronectin targeting contrast agent
#187Method of colorectal cancer detection by using radiolabeled anti-GRP78 peptide
#188Compositions and methods comprising phosphatidylethanolamine-binding peptide derivatives
#189Peptide ligands for clusterin and uses thereof
#190Compounds modulators of VEGF activity and uses thereof
#191Synthetic diblock copolypeptide hydrogels for use in the central nervous system
#192Imaging probes, methods of making imaging probes, and methods of imaging
#193METHODS FOR MAGNETIC RESONANCE IMAGING
#194Peptides whose uptake by cells is controllable
#195Gastrin releasing peptide compounds
#196TARGETING NPR-C IN ANGIOGENESIS AND ATHEROSCLEROSIS WITH A C-TYPE ATRIAL NATRIURETIC FACTOR (CANF)-COMB NANOCOMPLEX
#197BIOMOLECULE COMPLEXES AS CONTRAST AGENTS IN POSITRON EMISSION TOMOGRAPHY (PET) BASED METHODS FOR THE ASSESSMENT OF ORGAN FUNCTION
#198Metastasis-specific peptides and their diagnostic and therapeutic applications
#199Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#200MAGNETIC NANOPARTICLE AND METHOD FOR IMAGING T CELLS
#201Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GBexpressing tumors
#202PEPTIDE TARGETING IMAGING AGENTS AND METHODS OF USE THEREOF
#203Ligands to radiation-induced molecules
#204Probe reagent for measuring oxidative stress
#205Compounds for the diagnosis of diseases associated with VCAM expression
#206VECTOR FOR USE IN MEDICINE
#207METHOD FOR THE DETECTION OF ENZYMATIC ACTIVITY WITH MAGNETICALLY FUNCTIONALIZED SUBSTRATES
#208Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
#209METALLOPROTEIN MRI CONTRAST AGENTS AND RELATED METHODS
#210TREATMENT MONITORING
#211Elastin-like polypeptide and gadolinium conjugate for magnetic resonance imaging
#212Xe biosensors and their use
#213Flexibly labeling peptides
#214CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND METHODS OF IMAGING
#215Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
#216Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules
#217Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#218RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors
#219IN VIVO IMAGING
#220Agents for detecting and imaging cell death
#221Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors
#222COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#223Imaging method
#224ANTIOXIDANT AND PARAMAGNETIC HEPARIN-NITROXIDE DERIVATIVES
#225COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF
#226Magnetosome gene expression in eukaryotic cells
#227Particles for imaging
#228Diagnostic agent
#229Procaspase 8-mediated disease targeting
#230ACTIVATABLE DIAGNOSTIC AND THERAPEUTIC COMPOUND
#231PHAGE DISPLAY PEPTIDE PROBES FOR IMAGING EARLY RESPONSES TO ANTIANGIOGENIC TREATMENT
#232SMART CONTRAST AGENT AND METHOD FOR DETECTING TRANSITION METAL IONS AND TREATING RELATED DISORDERS
#233METASTASIS-SPECIFIC PEPTIDES AND THEIR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
#234Cupredoxin derived transport agents and methods of use thereof
#235Nuclear translocation peptide
#236Fibrin binding peptide conjugates for diagnostic and therapeutic applications
#237PARAMAGNETIC BIOMOLECULE COMPLEXES AND USES THEREOF IN THE ASSESSMENT OF ORGAN FUNCTION
#238Fibrin-binding peptides and conjugates thereof
#239COMPOUNDS FOR THE DIAGNOSIS OF APOPTOSIS
#240SMART CONTRAST AGENT AND DETECTION METHOD FOR DETECTING TRANSITION METAL IONS
#241COMPOSITIONS AND METHODS FOR THE DETECTION OF VULNERABLE PLAQUE
#242Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
#243Metastasis-specific peptides and their diagnostic and therapeutic applications
#244Two helix binders
#245Natriuretic peptide-mediated imaging of atherosclerotic plaque
#246Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
#247RADIOFLUORINATION METHODS
#248Protein Nanoparticles and the Use of the Same
#249Contrast agents
#250METHOD AND PRODUCT FOR LOCATING AN INTERNAL BLEEDING SITE
#251Highly fluorinated oils and surfactants and methods of making and using same
#252Magnetic resonance contrast medium containing an iron-binding protein
#253Imaging agents and methods of using same for detecting multidrug resistance in cancer
#254Methods and compositions related to targeting tumors and wounds
#255Contrast agents
#256USE OF VCAM-1 LIGANDS FOR DETECTING AND/OR TREATING CARDIOVASCULAR DISEASES
#257PDGF-Rβ binders
#258Gastrin releasing peptide compounds
#259Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
#260METHOD FOR THE SYNTHESIS OF PENTA-PENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIOCONJUGATES PREPARATION BY A COVALENT BINDING THEREOF
#261Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#262Glyco-molecular imaging method for grade classification of liver fibrosis and its glyco-molecular imaging agent thereof
#263Activatable cest MRI agent
#264SUPRAMOLECULAR AGGREGATES CONTAINING CHELATING AGENTS AND BIOACTIVE PEPTIDES AS EFFECTIVE AND SELECTIVE DELIVERY TOOLS FOR DRUGS AND CONTRAST AGENTS IN MRI OR NUCLEAR MEDICINE
#265Targeted contrast agents and methods for targeting contrast agents
#266Methods for attenuating virus strains for diagnostic and therapeutic uses
#267Octameric Protein For Use In Bionanotechnology Applications
#268Contrast agents and methods for preparing contrast agents
#269Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates
#270Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#271Compositions and methods for magnetic resonance imaging contrast agents
#272Self-etching emulsion dental compositions and methods
#273RADIOFLUORINATION
#274Polypeptides
#275Self-etching dental compositions and methods
#276Methods and compositions for delivering active agents with enhanced pharmacological properties
#277Chemical exchange saturation transfer based MRI using reporter genes and MRI methods related thereto
#278Targeted Imaging And/Or Therapy Using The [3+2] Azide-Alkyne Cycloaddition
#279Lipoprotein-Based Nanoplatforms
#280Compositions and methods to prevent cancer with cupredoxins
#281Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#282LABELING REACTANT
#283SYSTEMS AND METHODS FOR HIGH-RESOLUTION IN VIVO IMAGING OF BIOCHEMICAL ACTIVITY IN A LIVING ORGANISM
#284Flexibly labeling peptides
#285Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization
#286Methods and Compositions for Imaging and Biomedical Applications
#287Gastrin Releasing Peptide Compounds
#288Nanoparticles and their use for multifunctional bioimaging
#289NOVEL NANOPARTICLES AND USE THEREOF
#290Dual function polymer micelles
#291Optically pure and enriched isomers of chelating ligands and contrast agents
#292Peptide conjugates
#293Compositions and methods for locating an internal bleeding site
#294Peptide-Based Multimeric Targeted Contrast Agents
#295Labeling reactant
#296Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy
#297Fibrin targeted therapeutics
#298Radiopharmaceuticals for cancer diagnosis and treatment
#299Peptides whose uptake by cells is controllable
#300Stationary target imaging